Cardiac troponin T elevation after coronary artery bypass grafting is associated with increased one-year mortality

Sekar Kathiresan1, Stephen J Servoss, John B Newell

  • 1Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.

Insights

Assessing troponin T levels after coronary artery bypass grafting (CABG) helps predict mortality one year post-surgery. This finding supports using troponin T to forecast both short-term and long-term adverse outcomes in CABG patients.

Area of Science:

  • Cardiology
  • Biomarkers
  • Cardiac Surgery

Background:

  • Coronary artery bypass grafting (CABG) is a common cardiac surgery.
  • Predicting patient outcomes after CABG is crucial for clinical management.
  • Troponin T is a cardiac biomarker of interest for risk stratification.

Purpose of the Study:

  • To evaluate the predictive value of postoperative troponin T levels for 1-year mortality after CABG.
  • To reinforce the utility of troponin T in assessing adverse outcomes post-CABG.

Main Methods:

  • Postoperative assessment of troponin T levels in patients undergoing CABG.
  • Statistical analysis to correlate troponin T levels with 1-year mortality rates.
  • Comparison with existing data on in-hospital outcomes.

Main Results:

  • Elevated postoperative troponin T levels are associated with increased 1-year mortality after CABG.
  • The study confirms the prognostic value of troponin T for long-term survival post-CABG.
  • Findings align with previous research on troponin T and in-hospital adverse events.

Conclusions:

  • Postoperative troponin T assessment is valuable for predicting 1-year mortality risk in CABG patients.
  • Troponin T serves as a reliable biomarker for both short-term and long-term risk stratification following CABG.
  • Clinical guidelines should consider troponin T monitoring for enhanced patient management post-CABG.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...